Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Ovarian Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02441140
What this trial is testing

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian Cancer
Dana-Farber Cancer Institute 5
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Not applicableStudy completedNCT00003763
What this trial is testing

Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer

Who this might be right for
Ovarian Cancer
Endocyte 35
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Study completedNCT00831636
What this trial is testing

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Clavis Pharma 28
Large-scale testing (Phase 3)Looking for participantsNCT06580314
What this trial is testing

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Who this might be right for
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaFallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor+9 more
NRG Oncology 880
Testing effectiveness (Phase 2)Study completedNCT00003944
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT00042952
What this trial is testing

Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer

Who this might be right for
Ovarian DysgerminomaRecurrent Malignant Testicular Germ Cell TumorRecurrent Ovarian Germ Cell Tumor+5 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT00390611
What this trial is testing

Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
SCRI Development Innovations, LLC 85
Early research (Phase 1)Study completedNCT01440998
What this trial is testing

Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT00986206
What this trial is testing

Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierOvarian Cancer
Women and Infants Hospital of Rhode Island 525
Testing effectiveness (Phase 2)UnknownNCT02033616
What this trial is testing

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas

Who this might be right for
Stage III Ovarian CarcinomaStage IV Ovarian CarcinomaFallopian Tube Carcinoma+1 more
Aivita Biomedical, Inc. 99
Large-scale testing (Phase 3)Study completedNCT00102414
What this trial is testing

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
AGO Study Group 356
Not applicableNot Yet RecruitingNCT07465133
What this trial is testing

Updating the EORTC Quality-of-Life Questionnaire for Ovarian Cancer (QLQ-OV38)

Who this might be right for
Ovarian CancerQuality of Life
Helios University Hospital Wuppertal 50
Large-scale testing (Phase 3)Study completedNCT00006454
What this trial is testing

Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian Cancer
AGO Study Group
Not applicableUnknownNCT05840029
What this trial is testing

VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES

Who this might be right for
Ovarian Cancer
Alexandria University 68
Large-scale testing (Phase 3)Study completedNCT00003120
What this trial is testing

S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
SWOG Cancer Research Network 308
Testing effectiveness (Phase 2)Study completedNCT00083122
What this trial is testing

Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Recurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity CancerStage IIIA Ovarian Epithelial Cancer+7 more
National Cancer Institute (NCI) 45
Large-scale testing (Phase 3)UnknownNCT01654146
What this trial is testing

ICON8: Weekly Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Medical Research Council 1,485
Large-scale testing (Phase 3)UnknownNCT00715286
What this trial is testing

Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study

Who this might be right for
Ovarian Carcinoma
All India Institute of Medical Sciences 180
Next Page